Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer.
about
Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reductionPrognostic significance of volume-based PET parameters in cancer patients.Bioenergetic analysis of ovarian cancer cell lines: profiling of histological subtypes and identification of a mitochondria-defective cell line.Prognostic Significance of Metabolic Tumor Volume Measured by (18)F-FDG PET/CT in Operable Primary Breast Cancer.Metabolic Tumor Volume Measured by F-18 FDG PET/CT can Further Stratify the Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer.Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.Positron Emission Tomography (PET) in OncologyFDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases.Nerve Sheath Tumors in Neurofibromatosis Type 1: Assessment of Whole-Body Metabolic Tumor Burden Using F-18-FDG PET/CT.Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1.Impact of point spread function modelling and time of flight on FDG uptake measurements in lung lesions using alternative filtering strategiesDiagnostic and prognostic evaluation of fluorodeoxyglucose positron emission tomography/computed tomography and its correlation with serum cancer antigen-125 (CA125) in a large cohort of ovarian cancer patientsPrognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status.Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery.Total Lesion Glycolysis Using ¹⁸F-FDG PET/CT as a Prognostic Factor for Locally Advanced Esophageal Cancer.Preoperative Volume-Based PET Parameter, MTV2.5, as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer.Metabolic tumor burden predicts prognosis of ovarian cancer patients who receive platinum-based adjuvant chemotherapy.Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patientsIdentification of Metabolic Biomarkers Using Serial 18F-FDG PET/CT for Prediction of Recurrence in Advanced Epithelial Ovarian CancerUtility of 18F-FDG PET/CT in follow-up of patients with low-grade serous carcinoma of the ovary.PET/CT versus MRI for diagnosis, staging, and follow-up of lung cancer.Prognostic value of total lesion glycolysis on preoperative 18F-FDG PET/CT in patients with uterine carcinosarcoma.Metabolic Tumor Volume by 18F-FDG PET/CT Can Predict the Clinical Outcome of Primary Malignant Spine/Spinal Tumors.Molecular imaging in ovarian cancer.An update on the role of PET/CT and PET/MRI in ovarian cancer.Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.Guidelines for quality control of PET/CT scans in a multicenter clinical studyPET quantification with a histogram derived total activity metric: superior quantitative consistency compared to total lesion glycolysis with absolute or relative SUV thresholds in phantoms and lung cancer patients.Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on ¹⁸F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma.Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma.Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma.Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers.Prognostic importance of peritoneal lesion-to-primary tumour standardized uptake value ratio in advanced serous epithelial ovarian cancer.Diagnostic imaging using positron emission tomography for gynecological malignancy.Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours.What's New in Imaging for Gynecologic Cancer?The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.Prognostic Value of Volume-Based Positron Emission Tomography/Computed Tomography in Nasopharyngeal Carcinoma Patients after Comprehensive Therapy.
P2860
Q26786610-3C46FE4A-5D53-44BE-92B0-2CF8E5B88673Q27687836-F83D9516-69DA-4F59-8583-40A3F1C3FC0FQ33655175-9083962D-6125-4CED-8C56-7ECC55465D00Q33704628-992D46F4-D811-46D3-B126-675E44BA129FQ33704656-C22FED56-E068-481B-A256-7EE3B2D89A90Q33735128-1013DF44-0738-4DF0-9790-947C7697430AQ34774840-D4118764-C818-4916-B261-B169C3DB4BC3Q35043725-E3BDA671-F8C3-4169-BF6F-F978E6EA1581Q35761121-C4AA4221-B301-4227-8487-3CA5C1898864Q35857307-AAF39B10-82CF-4BE2-B4B1-16CDCC3725A9Q35961361-ADDC3C9E-7F0A-4211-8326-6E6CBEB2B0DAQ35983497-C92B87E4-12FC-4064-B5AF-1549ABCBAEEBQ36029023-0B882FAD-7928-47F5-BF86-2DDD386FF767Q36060090-8429118D-7388-4306-B6D3-7CFE9C6AF71FQ36132602-15593591-DE7A-4BB3-94A5-BC36A17A4C01Q36461563-4AFE760E-850C-482F-B2A8-1F932EDC1A9CQ36663805-3E47F419-478B-4713-B4F0-48F9C399A0E6Q36801193-8541EE59-5670-46DF-8573-531F38A260E3Q37153528-DFA4A8C5-111D-4040-A2CC-95E5872A1D92Q37715868-48EA7658-E61E-46C0-9F69-007174B31F17Q37724181-C986A885-9314-48F4-B1FF-DC9B6B8DC8ADQ38264614-0F9F06B4-74AB-4907-B0EC-70AFDDD150E6Q38417118-3C6D23AE-956C-4781-BEC8-8FF125EAE5C9Q38602774-5E7E3997-83E2-4FE2-BC70-B4E0F5B116AEQ38824319-C8AF9B97-4C4E-41B0-BEEE-F58ADD5BEC8AQ39127714-2EEF4FF3-2135-4AF1-A051-98884ABE4360Q40527607-912ACAE4-00B2-40BB-9254-756BCC9FF5D0Q41683890-29195422-C5BA-4806-9882-CD53998CF393Q42721856-10D0C4DE-BEF0-43FB-B77C-2ABC6A8B490EQ43526833-E8DCB98D-E39E-46D5-A57C-518813CB9D0EQ45849759-4B0C0936-1C8B-4043-8E29-0A28A46A4AA5Q45917673-DC54682D-E0CD-41BC-A7CE-350107943571Q46284024-670CFDE0-D653-4FB5-A736-D760D4385C07Q46506999-ED4EF8AA-FCAD-42F8-8883-03EC301B134FQ47279109-B2FF2BAB-C272-4937-87A1-0A7392C6B696Q48105266-942F13AE-979A-4E83-A604-98449E2E8F61Q49147470-DF33BBF2-01E4-4BDE-AF3E-536C6C079EB3Q50145613-1CE3E86F-27AE-4132-B371-C927E095E699Q53027673-E08C568C-A39F-4788-B8AF-611EED6A8373Q55255644-26A13782-67C5-489E-8465-32639FB2E2DC
P2860
Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Prognostic value of preoperati ...... ith epithelial ovarian cancer.
@en
Prognostic value of preoperati ...... ith epithelial ovarian cancer.
@nl
type
label
Prognostic value of preoperati ...... ith epithelial ovarian cancer.
@en
Prognostic value of preoperati ...... ith epithelial ovarian cancer.
@nl
prefLabel
Prognostic value of preoperati ...... ith epithelial ovarian cancer.
@en
Prognostic value of preoperati ...... ith epithelial ovarian cancer.
@nl
P2093
P2860
P1476
Prognostic value of preoperati ...... ith epithelial ovarian cancer.
@en
P2093
Hyun Hoon Chung
Hyun Woo Kwon
June-Key Chung
Keon Wook Kang
Noh-Hyun Park
Soon-Beom Kang
Yong-Sang Song
P2860
P2888
P304
P356
10.1245/S10434-011-2153-X
P50
P577
2011-11-29T00:00:00Z
P6179
1024196126